Google Translate Limitations Disclaimer

The electronic translation service on the brainXchange website is hosted by Google Translate, an external translation service. The brainXchange does not guarantee or warrant the reliability, accuracy or completeness of any translated information. The basic translation goal is to capture the general information of the original English website content. If any questions arise related to the accuracy of the information contained in the translated website, please refer to the English version of the website.

SE KEN Home > SE KEN On-Demand Recordings > 2017 > Pharmacological Management of Neuropsychiatric Symptoms of Dementia: Best Practice and New Evidence

Pharmacological Management of Neuropsychiatric Symptoms of Dementia: Best Practice and New Evidence

Event Date: Feb 14, 2017

Recording | Related Resources

Neuropsychiatric symptoms (NPS) affect over 80% of individuals with dementia at some point in their illness and pharmacological therapies can play an important role in the management of these symptoms. Several medications have been evaluated for the management of specific NPS and there is a rapidly growing evidence base related to the efficacy and safety of medications for the management of NPS. This presentation will review best practices in the use of medications commonly used in management of NPS and review new medications that are being evaluated for the management of NPS in older adults with dementia.

Presenter(s):

Dr. Dallas Seitz MD PhD, Associate Professor of Psychiatry and Chair of the Division of Geriatric Psychiatry, Queen's University; President, Canadian Academy of Geriatric Psychiatry